clinical trial · NCT07231757
The RADIANCE CED Study
ReCor Medical, Inc.·—·recruiting·n = 1,000
HypertensionCardiovascular DiseasesVascular DiseasesUltrasound Renal Denervation (Paradise™ Ultrasound Renal Denervation (uRDN) System)
brief summary
The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension. Data will be collected from electronic health records (EHRs) of Medicare-eligible patients to support generalizability of outcomes to the broader Medicare population. Individual hospital enrollment is not required for this study and IRB exemption has been received by sponsor.
started
Nov 21, 2025
primary completion
Dec 31, 2029
completion
Dec 31, 2031
last updated
Jan 9, 2026
official title
The Recor Paradise System™ Hypertension Coverage With Evidence Development Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol